Many of our previous in vitro studies involving susceptibility testing of amphotericin B against clinical isolates of pathogenic fungi were performed using a broth medium originally recommended by Groves and Randall for use in microbiological assay of this drug (1) . This medium, known as antibiotic medium 20 FDA (M-20), more recently has been recommended for routine use in susceptibility testing with both amphotericin B and nystatin (3) . Unfortunately, commercial production of M-20 has been discontinued.
With the nonavailability of M-20, it became necessary to choose another medium that would yield diagnostically similar results in in vitro susceptibility tests. A somewhat similar medium, antibiotic medium 3 FDA (Difco Laboratories, M-3) was selected. The main differences between these two media are in the total amounts of yeast extract, dextrose, and tryptone. M-3 contains 5 g of yeast extract per liter less and 10 g of dextrose per liter less than does M-20, whereas M-20 contains 10 g of tryptone per liter. All other constituents of the two media are similar ( Table 1) .
A brief study was undertaken to compare the two media and to determine if M-3 would be suitable for in vitro susceptibility testing with amphotericin B. Minimal inhibitory (MIC) and minimal fungicidal (MFC) concentrations were determined in both media for a variety of pathogenic yeasts in parallel using a previously described broth dilution method (3). Concentrations of amphotericin B ranged from 50 to 0.05 jig/ml. The drug was initially dissolved in 100% (CH3)2SO, and a stock concentration of 100 ,ug/ ml was then prepared in 5% (CHA)2SO and maintained at -20°C. Five clinical isolates each of Cryptococcus neoformans and Candida albicans and four of Candida parapsilosis were tested. Saccharomyces cerevisiae ATCC 9763 was tested along with each isolate as a control. MIC end points were determined after 48 h of incubation at 30°C. The MIC was defined as the Results with this study indicate that M-3 can be used for susceptibility testing with yeastlike organisms and amphotericin B ( Table 2) . The MIC and MFC results in all 14 individual tests with the control organism S. cerevisiae were constant, 0.05 ,ug/ml, indicating uniformity of results. Most MIC and MFC values measured for the clinical isolates in M-3 were somewhat lower than those measured in M-20. Differences between MIC values measured in the two media were significant (t test, P < 0.001), but differences in MFC values were not. With only two isolates, Candida parapsilosis 7.1 and C. parapsilosis 7.6, was a higher MFC measured in M-3 than in M-20. These differences were not critical in determination of clinical susceptibility. Differences between inhibitory and fungicidal end points measured in the two media most likely could be attributed to a lesser production of acid in M-3, with a subsequent reduction in decay of active drug, because of the lower carbohydrate content of this medium. The adverse effect of an acidic pH on the activity of amphotericin B is the primary reason why unbuffered synthetic media, such as yeast nitrogen base, are unsuitable for in vitro testing with polyene compounds (2) .
